Resources
The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Biomarkers in Immuno-Oncology
Scaling Comparative Lung Cancer Studies Using Chromium Single Cell Gene Expression Flex
Translational & Preclinical Development
Chromium X: the Most Flexible Way to Single Cell
Single cell analysis has been a revolutionary breakthrough in biology. Understanding cellular diversity has enabled significant insights into intracellular mechanisms and their applications to health and disease. But for many researchers, single cell has been out of reach due to technical, cost-per-cell, and scalability challenges.
Translational & Preclinical Development
10x Genomics: Inside Visium Spatial Capture Technology
Visium Spatial Gene Expression incorporates whole transcriptome analysis for intact tissues sections with morphological context. Bringing these complementary methods together offers a previously inaccessible view of tissue biology.
Biomarkers in Immuno-Oncology
TruCulture: A Simple Whole Blood Collection and Culture System for Clinical Immunology Studies
Biomarkers in Immuno-Oncology
Simplify Spatial Imaging Maxpar IMC Cell Segmentation Kit
High-plex imaging starts with robust cell segmentation
Biomarkers in Immuno-Oncology
Bioanalytical Solutions for CAR-T and NK Cell Therapies
Synexa Life Sciences is a bioanalytical and biomarker services laboratory specializing in the development and validation of complex and custom designed assays with progression into clinical trial sample analysis.
Translational & Preclinical Development
Synexa Life Sciences: ProtoTrials®
Enhancing human ex vivo translational outcomes.
Biomarkers in Immuno-Oncology
Synexa Life Sciences: Bioanalytical Solutions for Immuno-oncology Therapeutics
Global leaders in specialist biomarker and bioanalysis research services.
Biomarkers in Immuno-Oncology
Synexa Biomarker and Bioanalytical Solutions
Complex solutions delivered on time and within budget.
Biomarkers in Immuno-Oncology
Rules Based Medicine: Human Services Catalog
Rules-Based Medicine (RBM), a Q2 Solutions Company, is a CLIA-certified immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and products.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things immuno